What does CUSIP 501147102 represent in this 13F holders report?

CUSIP 501147102 is the security identifier for KRYS - Krystal Biotech, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held KRYS - Krystal Biotech, Inc. - Common Stock in Q1 2023?

159 institutional investors reported KRYS - Krystal Biotech, Inc. - Common Stock for Q1 2023. Use the holders table for investor-level position and value details.

Krystal Biotech, Inc. - Common Stock (KRYS)

CUSIP: 501147102

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class: Equity / Common Stock
Shares outstanding: 29,067,614
Total 13F shares: 20,979,177
Share change: +121,784
Total reported value: $1,678,957,589
Put/Call ratio: 180%
Price per share: $80.06
Number of holders: 159
Value change: +$9,326,151
Number of buys: 75
Number of sells: 65

Quarterly Holders Quick Answers

What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2023
Previous quarter: Q4 2022

Recent filing periods for CUSIP 501147102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	7.3%	2,108,853	$167,063,335	—	31 Dec 2022	13F
Redmile Group, LLC	13F	Company	6.5%	1,896,645	$150,252,217	—	31 Dec 2022	13F
BlackRock Finance, Inc.	13F	Company	5.8%	1,699,596	$134,641,998	—	31 Dec 2022	13F
Avoro Capital Advisors LLC	13F	Company	4.9%	1,410,000	$111,700,200	—	31 Dec 2022	13F
LORD, ABBETT & CO. LLC	13F	Company	4.4%	1,278,022	$101,245,000	—	31 Dec 2022	13F
VANGUARD GROUP INC	13F	Company	4.1%	1,188,110	$94,122,075	—	31 Dec 2022	13F
STATE STREET CORP	13F	Company	3.6%	1,038,983	$82,308,233	—	31 Dec 2022	13F
Frazier Life Sciences Management, L.P.	13F	Company	3.4%	999,737	$79,199,165	—	31 Dec 2022	13F
CREDIT SUISSE AG/	13F	Company	2.3%	682,880	$54,097,753	—	31 Dec 2022	13F
PICTET ASSET MANAGEMENT SA	13F	Company	2.2%	625,979	$49,590,000	—	31 Dec 2022	13F
Point72 Asset Management, L.P.	13F	Company	1.9%	556,252	$44,066,283	—	31 Dec 2022	13F
First Light Asset Management, LLC	13F	Company	1.6%	473,691	$37,525,801	—	31 Dec 2022	13F
Hood River Capital Management LLC	13F	Company	1.5%	426,879	$33,817,354	—	31 Dec 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	412,127	$32,648,000	—	31 Dec 2022	13F
Artal Group S.A.	13F	Company	1.4%	400,000	$31,688,000	—	31 Dec 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.3%	389,285	$30,841,000	—	31 Dec 2022	13F
BRAIDWELL LP	13F	Company	1.2%	358,056	$28,365,196	—	31 Dec 2022	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.2%	339,331	$26,881,802	—	31 Dec 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	1%	302,716	$23,981,162	—	31 Dec 2022	13F
Skandinaviska Enskilda Banken AB (publ)	13F	Company	0.99%	287,541	$22,779,000	—	31 Dec 2022	13F
Nicholas Investment Partners, LP	13F	Company	0.92%	267,089	$21,158,791	—	31 Dec 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.82%	237,937	$18,849,000	—	31 Dec 2022	13F
C WorldWide Group Holding A/S	13F	Company	0.78%	225,809	$17,889,000	—	31 Dec 2022	13F
NORTHERN TRUST CORP	13F	Company	0.69%	201,288	$15,946,035	—	31 Dec 2022	13F
Soleus Capital Management, L.P.	13F	Company	0.65%	188,217	$14,910,551	—	31 Dec 2022	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.6%	175,000	$13,863,500	—	31 Dec 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.55%	160,615	$12,723,920	—	31 Dec 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.51%	147,601	$11,692,952	—	31 Dec 2022	13F
Integral Health Asset Management, LLC	13F	Company	0.4%	115,000	$9,110,300	—	31 Dec 2022	13F
S Squared Technology, LLC	13F	Company	0.37%	108,215	$8,572,792	—	31 Dec 2022	13F
ExodusPoint Capital Management, LP	13F	Company	0.36%	105,761	$8,378,000	—	31 Dec 2022	13F
Handelsbanken Fonder AB	13F	Company	0.36%	105,200	$8,334,000	—	31 Dec 2022	13F
Rubric Capital Management LP	13F	Company	0.32%	92,609	$7,336,485	—	31 Dec 2022	13F
Bank of New York Mellon Corp	13F	Company	0.28%	82,096	$6,503,645	—	31 Dec 2022	13F
Verition Fund Management LLC	13F	Company	0.28%	80,561	$6,382,042	—	31 Dec 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.23%	68,043	$5,390,366	—	31 Dec 2022	13F
MORGAN STANLEY	13F	Company	0.23%	66,051	$5,232,559	—	31 Dec 2022	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.22%	62,609	$4,959,885	—	31 Dec 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.21%	61,625	$4,881,933	—	31 Dec 2022	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.2%	58,535	$4,637,143	—	31 Dec 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.2%	57,412	$4,548,000	—	31 Dec 2022	13F
Monarch Partners Asset Management LLC	13F	Company	0.19%	53,905	$4,270,354	—	31 Dec 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.18%	52,676	$4,172,993	—	31 Dec 2022	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.16%	45,203	$3,581,000	—	31 Dec 2022	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.15%	45,000	$3,558,150	—	31 Dec 2022	13F
Swiss National Bank	13F	Company	0.15%	43,400	$3,438,148	—	31 Dec 2022	13F
UBS Group AG	13F	Company	0.15%	42,623	$3,376,594	—	31 Dec 2022	13F
SG Americas Securities, LLC	13F	Company	0.13%	38,774	$3,072,000	—	31 Dec 2022	13F
CWM, LLC	13F	Company	0.13%	37,130	$2,941,000	—	31 Dec 2022	13F
BARCLAYS PLC	13F	Company	0.13%	36,348	$2,879,489	—	31 Dec 2022	13F

Institutional Holders of Krystal Biotech, Inc. - Common Stock (KRYS) as of Q1 2023

As of 31 Mar 2023, Krystal Biotech, Inc. - Common Stock (KRYS) was held by 159 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,979,177 shares. The largest 10 holders included FMR LLC, Redmile Group, LLC, Avoro Capital Advisors LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, LORD, ABBETT & CO. LLC, Frazier Life Sciences Management, L.P., CREDIT SUISSE AG/, and PICTET ASSET MANAGEMENT SA. This page lists 159 institutional shareholders reporting positions in this security for the Q1 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders

153

Q1 2023 holders

159

Holder diff

Investor	Q4 2022 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q4 2022 Value $	Q1 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.